LivaNova PLC LivaNova Reports Fourth Quarter and Full-Year 2016 Results
01 Marzo 2017 - 1:00PM
UK Regulatory
TIDMLIVN
LivaNova Reports Fourth Quarter and Full-Year 2016 Results
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.
1 March 2017
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) ("LivaNova" or the
"Company"), a market-leading medical technology company, today
announced that, on 1 March 2017, LivaNova filed with the U.S.
Securities and Exchange Commission its Current Report on Form 8-K,
a copy of which can be found at www.sec.gov.
A copy of the Form 8-K is being submitted to the UK Listing
Authority via the National Storage Mechanism and will shortly be
available for inspection at
http://www.morningstar.co.uk/uk/nsm.
About LivaNova
LivaNova PLC is a global medical technology company built on
nearly five decades of experience and a relentless commitment to
improve the lives of patients around the world. LivaNova's advanced
technologies and breakthrough treatments provide meaningful
solutions for the benefit of patients, healthcare professionals and
healthcare systems. Headquartered in London and with a presence in
more than 100 countries worldwide, the company employs
approximately 4,600 employees.
LivaNova operates as three business franchises: Cardiac Surgery,
Neuromodulation and Cardiac Rhythm Management, with operating
headquarters in Mirandola (Italy), Houston (U.S.A.) and Clamart
(France), respectively.
For more information, please visit www.livanova.com or
contact:
Catherine Moroz
Company Secretary
Phone: +44 (0) 203 325 0662
e-mail: company.secretariat@livanova.com
Karen King
Vice President, Investor Relations & Corporate
Communications
Phone: +1 (281) 228-7262
Email: corporate.communications@livanova.com
View source version on businesswire.com:
http://www.businesswire.com/news/home/20170301005766/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
March 01, 2017 07:00 ET (12:00 GMT)
Grafico Azioni Livanova (LSE:LIVN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Livanova (LSE:LIVN)
Storico
Da Giu 2023 a Giu 2024